Research graph
References from GM-CSF Programs Alveolar Macrophages to Maintain Pulmonary Lymphocyte Homeostasis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1053/joca.1998.0164
10.1053/joca.1998.0164 · External reference
10.1378/chest.107.3_supplement.140s
10.1378/chest.107.3_supplement.140s · External reference
10.1172/jci28756
10.1172/jci28756 · External reference
10.1164/ajrccm.164.7.2103011
10.1164/ajrccm.164.7.2103011 · External reference
10.1148/radiology.212.3.r99se04637
10.1148/radiology.212.3.r99se04637 · External reference
10.3389/fimmu.2024.1437767
10.3389/fimmu.2024.1437767 · External reference
10.1016/j.cell.2024.05.021
10.1016/j.cell.2024.05.021 · External reference
Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease
10.1513/annalsats.202005-420oc · 2020 · External reference
Bronchoalveolar lavage in hypersensitivity pneumonitis: a series of 139 patients
10.2174/187152812798889330 · 2012 · External reference
10.1164/rccm.200308-1167oc
10.1164/rccm.200308-1167oc · External reference
10.1164/ajrccm/142.6_pt_1.1407
10.1164/ajrccm/142.6_pt_1.1407 · External reference
10.1183/09031936.00150208
10.1183/09031936.00150208 · External reference
10.1164/rccm.200608-1113oc
10.1164/rccm.200608-1113oc · External reference
10.1164/rccm.201906-1123oc
10.1164/rccm.201906-1123oc · External reference
10.1378/chest.122.6.2150
10.1378/chest.122.6.2150 · External reference
10.1378/chest.11-1880
10.1378/chest.11-1880 · External reference
STAT5b Deficiency: A Rare Cause of Pulmonary Alveolar Proteinosis
2019 · External reference
10.1165/rcmb.2011-0392tr
10.1165/rcmb.2011-0392tr · External reference
10.1152/ajplung.00203.2014
10.1152/ajplung.00203.2014 · External reference
10.1146/annurev.physiol.64.090601.113847
10.1146/annurev.physiol.64.090601.113847 · External reference
10.1056/nejmra023226
10.1056/nejmra023226 · External reference
Pulmonary alveolar proteinosis
10.1038/s41572-019-0066-3 · 2019 · External reference
10.1126/science.8171324
10.1126/science.8171324 · External reference
10.1073/pnas.91.12.5592
10.1073/pnas.91.12.5592 · External reference
10.1182/blood.v56.6.947.947
10.1182/blood.v56.6.947.947 · External reference
10.1016/s1074-7613(01)00218-7
10.1016/s1074-7613(01)00218-7 · External reference
10.1084/jem.20131199
10.1084/jem.20131199 · External reference
10.1084/jem.20210745
10.1084/jem.20210745 · External reference
10.1038/ni.3005
10.1038/ni.3005 · External reference
10.1073/pnas.92.21.9565
10.1073/pnas.92.21.9565 · External reference
A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous Csf2ra gene disruption
10.1152/ajplung.00175.2021 · 2022 · External reference
10.1016/s1471-4906(02)02260-3
10.1016/s1471-4906(02)02260-3 · External reference
10.1038/nri2356
10.1038/nri2356 · External reference
10.1084/jem.176.6.1693
10.1084/jem.176.6.1693 · External reference
10.1242/jcs.260298
10.1242/jcs.260298 · External reference
10.1038/srep15566
10.1038/srep15566 · External reference
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
10.1038/s41467-018-05491-z · 2018 · External reference
10.1038/s41598-017-10879-w
10.1038/s41598-017-10879-w · External reference
10.1038/mi.2015.84
10.1038/mi.2015.84 · External reference
10.4049/jimmunol.179.6.3488
10.4049/jimmunol.179.6.3488 · External reference
10.1038/34178
10.1038/34178 · External reference
10.1152/ajpendo.90632.2008
10.1152/ajpendo.90632.2008 · External reference
PPAR gamma and PGC-1alpha activators protect against diabetic nephropathy by suppressing the inflammation and NF-kappaB activation
10.1111/nep.14381 · 2024 · External reference
10.1038/nature03988
10.1038/nature03988 · External reference
10.4049/jimmunol.0803504
10.4049/jimmunol.0803504 · External reference
10.1016/j.immuni.2017.10.007
10.1016/j.immuni.2017.10.007 · External reference
10.1126/sciimmunol.abj0140
10.1126/sciimmunol.abj0140 · External reference
10.1182/blood.v98.9.2845
10.1182/blood.v98.9.2845 · External reference
10.4049/jimmunol.141.10.3383
10.4049/jimmunol.141.10.3383 · External reference
10.1165/rcmb.2005-0241oc
10.1165/rcmb.2005-0241oc · External reference
10.1038/nature13807
10.1038/nature13807 · External reference
10.1084/jem.119.1.167
10.1084/jem.119.1.167 · External reference
10.1016/1074-7613(95)90046-2
10.1016/1074-7613(95)90046-2 · External reference
10.1084/jem.190.6.875
10.1084/jem.190.6.875 · External reference
10.1084/jem.20080990
10.1084/jem.20080990 · External reference
10.1084/jem.20080759
10.1084/jem.20080759 · External reference
10.1038/ni973
10.1038/ni973 · External reference
10.1016/0002-9343(81)90577-5
10.1016/0002-9343(81)90577-5 · External reference
10.1126/scitranslmed.3009750
10.1126/scitranslmed.3009750 · External reference
10.1016/j.ymthe.2019.06.010
10.1016/j.ymthe.2019.06.010 · External reference
10.1172/jci5212
10.1172/jci5212 · External reference
10.1038/s41467-023-44184-0
10.1038/s41467-023-44184-0 · External reference
10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2984
10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2984 · External reference
10.1016/j.mito.2021.10.009
10.1016/j.mito.2021.10.009 · External reference
10.1002/jlb.46.2.119
10.1002/jlb.46.2.119 · External reference
Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis
10.1164/rccm.201306-1039oc · 2014 · External reference
10.1126/sciadv.adl4913
10.1126/sciadv.adl4913 · External reference
10.1126/science.aam8940
10.1126/science.aam8940 · External reference
10.1038/s41586-019-0969-x
10.1038/s41586-019-0969-x · External reference
10.1038/s41586-023-06720-2
10.1038/s41586-023-06720-2 · External reference
10.1371/journal.pone.0145342
10.1371/journal.pone.0145342 · External reference
The M1 and M2 paradigm of macrophage activation: time for reassessment
2014 · External reference
10.1371/journal.pone.0279037
10.1371/journal.pone.0279037 · External reference
10.1189/jlb.1a0314-170r
10.1189/jlb.1a0314-170r · External reference
